Subscribe to RSS
DOI: 10.1055/s-2006-956479
Efficient Synthesis of Bicyclic α-Hydroxy-α-trifluoromethyl-γ-lactams
Norio Shibata*, Hiroyuki Fujimoto, Satoshi Mizuta, Shinichi Ogawa, Yumi Ishiuchi, Shuichi Nakamura, Takeshi Toru*Department of Applied Chemistry, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso, Showa, Nagoya 466-8555, Japan
Fax: +81(52)7355442; e-Mail: nozshiba@nitech.ac.jp; e-Mail: toru@nitech.ac.jp;
Publication History
Received
25 September 2006
Publication Date:
08 December 2006 (online)
Abstract
A facile method for the synthesis of bicyclic 3-hydroxy-3-trifluoromethyl-γ-lactams using a variety of enamines and ethyl trifluoropyruvate with or without a catalyst was examined.
Key words
fluorine - tandem reactions - bicyclic compounds - heterocycle - green chemistry
-
1a
Filler R.Kobayashi Y. Biomedicinal Aspects of Fluorine Chemistry Elsevier Biomedical Press and Kodansya Ltd; Amsterdam: 1982. -
1b
Ojima I.MacCarthy JR.Welch JT. Biomedical Frontiers of Fluorine Chemistry, ACS Symposium Series American Chemical Society; Washington DC: 1996. -
1c
Welch JT.Eswarakrishman S. Fluorine in Bioorganic Chemistry Wiley; New York: 1991. -
1d
Filler R.Kobayashi Y.Yagupolskii LM. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications Elsevier; Amsterdam / New York: 1993. -
2a
Welch JT. Tetrahedron 1987, 43: 3123 -
2b
Kirsch P. Modern Fluoroorganic Chemistry Wiley-VCH; Weinheim: 2004. -
2c
Zhu SZ.Wang YL.Peng WM.Song LP.Jin GF. Curr. Org. Chem. 2002, 6: 1057 -
2d
Erian AW. J. Heterocycl. Chem. 2001, 38: 793 -
2e
Silvester MJ. Adv. Heterocycl. Chem. 1994, 59: 1 -
2f
Burger K. Adv. Heterocycl. Chem. 1994, 60: 1 -
2g
Lin P.Jiang J. Tetrahedron 2000, 56: 3635 - For examples, see:
-
3a
Barker M.Clackers M.Copley R.Demaine DA.Humphreys D.Inglis GGA.Johnston MJ.Jones HT.Haase MV.House D.Loiseau R.Nisbet L.Pacquet F.Skone PA.Shanahan SE.Tape D.Vinader VM.Washington M.Uings I.Upton R.McLay IM.Macdonald SJF. J. Med. Chem. 2006, 49: 4216 -
3b
Betageri R.Zhang Y.Zindell RM.Kuzmich D.Kirrane TM.Bentzien J.Cardozo M.Capolino AJ.Fadra TN.Nelson RM.Paw Z.Shih D.-T.Shih C.-K.Zuvela-Jelaska L.Nabozny G.Thomson DS. Bioorg. Med. Chem. Lett. 2005, 15: 4761 -
3c
Sani M.Viani F.Binda M.Zaffaroni N.Zanda M. Lett. Org. Chem. 2005, 2: 447 -
3d
Barker M.Clackers M.Demaine DA.Humphreys D.Johnston MJ.Jones HT.Pacquet F.Pritchard JM.Salter M.Shanahan SE.Skone PA.Vinader VM.Uings I.McLay IM.Macdonald SJF. J. Med. Chem. 2005, 48: 4507 -
3e
Pinna C.Sanvito P.Bolego C.Cignarella A.Puglisi L. Eur. J. Pharmacol. 2005, 516: 71 -
3f
Molteni M.Pesenti C.Sani M.Volonterio A.Zanda M. J. Fluorine Chem. 2004, 125: 1735 -
3g
Sculptoreanu A.Yoshimura N.de Groat WC. J. Pharmacol. Exp. Ther. 2004, 310: 159 - For examples, see:
-
4a
Labroo RB.Cohen LA. J. Org. Chem. 1990, 55: 4901 -
4b
Koguchi Y.Kohno J.Nishio M.Takahashi K.Okuda T.Ohnuki T.Komatsubara S. J. Antibiot. 2000, 53: 105 -
4c
Tang Y.-Q.Sattler I.Thiericke R.Grabley S.Feng X.-Z. Eur. J. Org. Chem. 2001, 261 -
4d
Suzuki H.Morita H.Shiro M.Kobayashi J. Tetrahedron 2004, 60: 2489 -
4e
Gorpinchenko VA.Yatsynich EA.Petrov DV.Karachurina LT.Hisamutdinova RY.Baschenko NZ.Dokichev VA.Tomilov YV.Yunusov MS.Nefedov OM. Pharm. Chem. J. 2005, 39: 289 -
4f
Meyers AI.Snyder L. J. Org. Chem. 1993, 58: 36 -
4g
Rigo B.Fasseur D.Cherepy N.Couturier D. Tetrahedron Lett. 1989, 30: 7057 -
4h
Nilsson BM.Ringdahl B.Hacksell U. J. Med. Chem. 1990, 33: 580 -
4i
Bergmann R.Gericke R. J. Med. Chem. 1990, 33: 492 -
4j
Damour D.Herman F.Labaudinière R.Pantel G.Vuilhorgne M.Mignani S. Tetrahedron 1999, 55: 10135 -
4k
Borthwick AD.Angier SJ.Crame AJ.Exall AM.Haley TM.Hart GJ.Mason AM.Pennell AMK.Weingarten GG. J. Med. Chem. 2000, 43: 4452 -
4l
Macdonald SJF.Inglis GGA.Bentley D.Dowle MD. Tetrahedron Lett. 2002, 43: 5057 -
4m
Kleinman EF.Campbell E.Giordano LA.Cohan VL.Jenkinson TH.Cheng JB.Shirley JT.Pettipher ER.Salter ED.Hibbs TA.DiCapua FM.Bordner J. J. Med. Chem. 1998, 41: 266 -
5a
Fukuzumi T.Shibata N.Sugiura M.Yasui H.Nakamura S.Toru T. Angew. Chem. Int. Ed. 2006, 45: 4973 -
5b
Shibata N.Ishimaru T.Nakamura M.Toru T. Synlett 2004, 2509 -
5c
Shibata N.Ishimaru T.Suzuki E.Kirk KL. J. Org. Chem. 2003, 68: 2494 -
5d
Shibata N.Tarui T.Doi Y.Kirk KL. Angew. Chem. Int. Ed. 2001, 40: 4461 -
5e
Shibata N.Suzuki E.Asahi T.Shiro M. J. Am. Chem. Soc. 2001, 123: 7001 -
5f
Takeuchi Y.Tarui T.Shibata N. Org. Lett. 2000, 2: 639 -
5g
Takeuchi Y.Shiragami T.Kimura K.Suzuki E.Shibata N. Org. Lett. 1999, 1: 1571 - 6
Viswanathan N.Rawle NN.Gawad DH. J. Chem. Res., Synop. 1985, 244 -
7a
Sviridov VD.Chkanikov ND.Galakhov MV.Shklyaev YV.Shklyaev VS.Aleksandrov BB.Gavrilov MS. Izv. Akad. Nauk. SSSR, Ser. Khim. 1990, 1405 -
7b
Sviridov VD.Chkanikov ND.Shklyaev YV.Kolomiets AF.Fokin AV. Khim. Geterotsikl. Soedin. 1990, 1689 -
7c
Aleksandrov BB.Gavrilov MS.Dautova RZ.Niyazov RK.Sviridov VD.Chkanikov ND.Syropyatov BY.Shklyaev VS.Sklyaev YV. Khim.-Farm. Zh. 1992, 26: 44 - For examples, see:
-
8a
Zhao J.-L.Liu L.Zhang H.-B.Wu Y.-C.Wang D.Chen Y. Tetrahedron Lett. 2006, 47: 2511 -
8b
Deb I.Dadwal M.Mobin SM.Namboothiri INN. Org. Lett. 2006, 8: 1201 -
8c
Sokolov VB.Aksinenko AY.Martynov IV. Russ. Chem. Bull. 2005, 54: 470 -
8d
Ding R.Zhang H.Chen Y.-J.Liu L.Wang D.Li C. Synlett 2004, 555 -
8e
Prakash GKS.Yan P.Török B.Olah GA. Synlett 2003, 527 -
8f
Kobel’kova NM.Osipov SN.Kolomiets AF. Russ. Chem. Bull. 2002, 51: 1298 -
8g
Golubev AS.Galakhov MV.Kolomiets AF.Fokin AV. Izv. Akad. Nauk. SSSR, Ser. Khim. 1991, 141 -
8h
Soloshonok VA.Rozhenko AB.Butovich IA.Kukhar VP. Zh. Org. Khim. 1990, 26: 2051 -
8i
Soloshonok VA.Kukhar VP. Zh. Org. Khim. 1990, 26: 419 -
8j
Golubev AS.Kolomiets AF.Fokin AV. Izv. Akad. Nauk. SSSR, Ser. Khim. 1989, 2369 - For examples, see:
-
9a
Suri JT.Mitsumori S.Albertshofer K.Tanaka F.Barbas CF. J. Org. Chem. 2006, 71: 3822 -
9b
Lyle MPA.Draper ND.Wilson PD. Org. Lett. 2005, 7: 901 -
9c
Du M.Lu S.-F.Fang T.Xu J. J. Org. Chem. 2005, 70: 3712 -
9d
Mikami K.Kakuno H.Aikawa K. Angew. Chem. Int. Ed. 2005, 44: 7257 -
9e
Zhuang W.Poulsen TB.Jørgensen KA. Org. Biomol. Chem. 2005, 3: 3284 -
9f
Török B.Abid M.London G.Esquibel J.Török M.Mhadgut SC.Yan P.Prakash GKS. Angew. Chem. Int. Ed. 2005, 44: 3086 -
9g
Mikami K.Aikawa K.Kainuma S.Kawakami Y.Saito T.Sayo N.Kumobayashi H. Tetrahedron: Asymmetry 2004, 15: 3885 -
9h
Lu S.-F.Du D.-M.Zhang S.-W.Xu J. Tetrahedron: Asymmetry 2004, 15: 3433 -
9i
Gathergood N.Juhl K.Poulsen TB.Thordrup K.Jørgensen KA. Org. Biomol. Chem. 2004, 2: 1077 -
9j
Bøgevig A.Gothelf KV.Jørgensen KA. Chem. Eur. J. 2002, 8: 5652 -
9k
Corma A.García H.Moussaif A.Sabater MJ.Zniber R.Redouane A. Chem. Commun. 2002, 1058 -
9l
Bøgevig A.Kumaragurubaran N.Jørgensen KA. Chem. Commun. 2002, 620 -
9m
Zhuang W.Gathergood N.Hazell RG.Jørgensen KA. J. Org. Chem. 2001, 66: 1009 -
9n
Gathergood N.Zhuang W.Jørgensen KA. J. Am. Chem. Soc. 2000, 122: 12517 -
10a
Paleček J.Paleta O. Synthesis 2004, 521 -
10b
Volochnyuk DM.Kostyuk AN.Sibgatulin DA.Petrenko AE. Synthesis 2004, 2545 - 13
Furukawa Y, andKishimoto E. inventors; Jpn. Kokai Tokkyo Koho JP 226351A. - 14
Shipchandler MT.Mitscher LA. J. Heterocycl. Chem. 1971, 8: 695
References and Notes
Although a literature survey on SciFinder® reveals the types of compounds 1 as being registered, surprisingly, neither references nor the synthetic information on them is available.
12Compound 1a: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.02-2.18 (m, 2 H), 2.26-2.66 (m, 4 H), 4.37 (br s, 1 H), 4.65 (d, J = 15.8 Hz, 1 H), 4.89 (d, J = 15.8 Hz, 1 H), 7.15-7.20 (m, 2 H), 7.31-7.42 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3128, 1763, 1632, 1601, 1413, 1359, 1263, 1183, 1158, 1075, 1026, 960, 945, 737, 712, 568, 499 cm-1. MS (EI): m/z = 325 [M+].
Compound 1b: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.09-2.22 (m, 2 H), 2.36-2.68 (m, 4 H), 4.48 (br s, 1 H), 7.19-7.25 (m, 2 H), 7.45-7.56 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.4 (s, 3 F). IR (KBr): 3424, 1767, 1651, 1613, 1496, 1399, 1255, 1191, 1086, 1015, 849, 744, 715, 552 cm-1. MS (EI): m/z = 311 [M+].
Compound 1c: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.75-1.97 (m, 4 H), 2.10-2.35 (m, 1 H), 2.34-2.50 (m, 1 H), 2.86-3.04 (m, 2 H), 3.62 (ddd, J = 14.0, 7.6, 5.6 Hz, 1 H), 3.87 (dt, J = 14.0, 6.2 Hz, 1 H), 4.34 (d, J = 4.2 Hz, 1 H), 7.08-7.14 (m, 2 H), 7.27-7.32 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.0 (s, 3 F). IR (KBr): 3250, 2960, 1764, 1638, 1593, 1458, 1433, 1366, 1336, 1277, 1256, 1184, 1161, 1072, 985, 946, 841, 755, 708, 562, 499 cm-1. MS (EI): m/z = 339 [M+].
Compound 1d: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.05 (s, 3 H), 1.07 (s, 3 H), 2.24 (d, J = 16.6 Hz, 1 H), 2.35 (s, 2 H), 2.38 (d, J = 16.6 Hz, 1 H), 4.26 (br s, 1 H), 4.66 (d, J = 16.0 Hz, 1 H), 4.89 (d, J = 16.0 Hz, 1 H), 7.13-7.18 (m, 2 H), 7.31-7.41 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.0 (s, 3 F). IR (KBr): 3201, 2961, 1756, 1625, 1599, 1421, 1267, 1191, 1173, 1062, 956, 701 cm-1. MS (EI): m/z = 353 [M+].
Compound 1e: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.12 (s, 3 H), 1.14 (s, 3 H), 2.29 (d, J = 18.6 Hz, 1 H), 2.23 (d, J = 16.4 Hz, 1 H), 2.41 (d, J = 18.6 Hz, 1 H), 2.45 (d, J = 16.4 Hz, 1 H), 4.44 (br s, 1 H), 7.17-7.22 (m, 2 H), 7.47-7.53 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.0 (s, 3 F). IR (KBr): 3398, 3222, 2962, 1766, 1647, 1615, 1496, 1400, 1244, 1192, 1163, 1074, 1048, 897, 742, 715, 571, 505, 449 cm-1. MS (EI): m/z = 339 [M+].
Compound 1f: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 0.85 (s, 3 H), 0.95 (s, 3 H), 1.67 (d, J = 18.2 Hz, 1 H), 1.80 (d, J = 18.2 Hz, 1 H), 2.10 (d, J = 16.4 Hz, 1 H), 2.22 (d, J = 16.4 Hz, 1 H), 2.80-3.03 (m, 2 H), 3.60 (ddd, J = 14.0, 7.8, 5.6 Hz, 1 H), 3.89 (dt, J = 14.2, 6.0 Hz, 1 H), 4.28 (br s, 1 H), 7.10-7.14 (m, 2 H), 7.31-7.34 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -77.8 (s, 3 F). IR (KBr): 3200, 2962, 1755, 1642, 1605, 1422, 1263, 1189, 1167, 1068, 701, 497 cm-1. MS (EI): m/z = 367 [M+].
Compound 5g: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.31 (t, J = 7.2 Hz, 3 H), 1.75-1.93 (m, 2 H), 2.27-2.37 (m, 2 H), 2.47-2.62 (m, 2 H), 4.17-4.34 (m, 2 H), 5.76 (d, J = 6.4 Hz, 1 H), 6.06 (s, 1 H), 7.21-7.42 (m, 10 H), 7.69 (d, J = 6.4 Hz, 1 H). 19F NMR (188 MHz, CDCl3): δ = -76.1 (s, 3 F). IR (KBr): 3321, 2953, 1747, 1565, 1432, 1373, 1281, 1193, 1034, 991, 946, 744, 704, 550 cm-1. MS (EI): m/z = 447 [M+].
Compound 1g: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.86-2.06 (m, 3 H), 2.18-2.54 (m, 3 H), 4.20 (br s, 1 H), 6.81 (s, 1 H), 7.15-7.20 (m, 4 H), 7.33-7.45 (m, 6 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3400, 3064, 3033, 2954, 1759, 1647, 1603, 1243, 1191, 1165, 1076, 1013, 741, 715, 700, 612, 512, 418 cm-1. MS (EI): m/z = 401 [M+].
Compound 1h: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 0.93 (s, 3 H), 1.01 (s, 3 H), 1.89 (d, J = 18.2 Hz, 1 H), 2.09 (d, J = 18.2 Hz, 1 H), 2.16 (d, J = 16.4 Hz, 1 H), 2.31 (d, J = 16.4 Hz, 1 H), 4.29 (br s, 1 H), 6.83 (s, 1 H), 7.17-7.21 (m, 4 H), 7.34-7.41 (m, 6 H). 19F NMR (188 MHz, CDCl3): δ = -77.9 (s, 3 F). IR (KBr): 3390, 2962, 1765, 1646, 1600, 1424, 1405, 1356, 1266, 1225, 1193, 1161, 1078, 1067, 904, 743, 702, 567, 447 cm-1. MS (EI): m/z = 429 [M+].
Compound 1i: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.13-2.24 (m, 2 H), 2.32-2.62 (m, 4 H), 4.41 (br s, 1 H), 4.68 (d, J = 16.4 Hz, 1 H), 5.09 (d, J = 16.4 Hz, 1 H), 7.64 (s, 2 H), 7.87 (s, 1 H). 19F NMR (188 MHz, CDCl3): δ = -63.0 (s, 6 F), -78.3 (s, 3 F). IR (KBr): 3545, 1764, 1645, 1612, 1408, 1353, 1281, 1184, 1133, 1081, 957, 708, 684 cm-1. MS (EI): m/z = 461 [M+].
Compound 1j: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 2.02-2.16 (m, 2 H), 2.29-2.59 (m, 4 H), 4.39 (br s, 1 H), 4.88 (d, J = 16.8 Hz, 1 H), 5.12 (d, J = 16.8 Hz, 1 H), 7.09 (d, J = 7.6 Hz, 1 H), 7.44 (t, J = 7.6 Hz, 1 H), 7.56 (t, J = 7.6 Hz, 1 H), 7.72 (t, J = 7.6 Hz, 1 H). 19F NMR (188 MHz, CDCl3): δ = -60.1 (s, 3 F), -78.0 (s, 3 F). IR (KBr): 3126, 2813, 1760, 1645, 1612, 1409, 1319, 1263, 1157, 1110, 1080, 1039, 967, 946, 878, 770, 709, 657, 426 cm-1. MS (EI): m/z = 393 [M+].
Compound 1k: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.79-1.98 (m, 4 H), 2.63-2.71 (m, 4 H), 4.65 (d, J = 16.2 Hz, 1 H), 4.97 (d, J = 16.2 Hz, 1 H), 5.99 (s, 1 H), 7.13-7.17 (m, 2 H), 7.29-7.40 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3384, 3011, 2948, 2883, 1761, 1590, 1403, 1320, 1259, 1207, 1171, 1039, 944, 743, 710, 627, 525, 463 cm-1. MS (EI): m/z = 339 [M+].
Compound 1l: brown oil. 1H NMR (200 MHz, CDCl3): δ = 2.23 (s, 3 H), 4.79 (d, J = 16.0 Hz, 1 H), 4.87 (d, J = 16.0 Hz, 1 H), 7.10-7.17 (m, 2 H), 7.30-7.36 (m, 3 H). 19F NMR (188 MHz, CDCl3): δ = -78.6 (s, 3 F). IR (neat): 3341, 2220, 1748, 1633, 1402, 1352, 1267, 1181, 1139, 1083, 1032, 953, 742, 716, 614, 557 cm-1. MS (EI): m/z = 296 [M+].
Compound 4: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.80 (br s, 1 H), 4.65 (d, J = 15.8 Hz, 1 H), 5.10 (d, J = 15.8 Hz, 1 H), 5.65 (br s, 1 H), 6.34 (d, J = 7.6 Hz, 1 H), 6.65 (d, J = 8.4 Hz, 1 H) 7.15-7.40 (m, 6 H). 19F NMR (188 MHz, CDCl3): δ = -78.1 (s, 3 F). IR (KBr): 3592, 3471, 3338, 3239, 1721, 1618, 1471, 1388, 1352, 1281, 1174, 1123, 1038, 948, 788, 702 cm-1. MS (EI): m/z = 323 [M+].
Compound 5m: colorless crystals. 1H NMR (200 MHz, CDCl3): δ = 1.34 (t, J = 7.2 Hz, 3 H), 2.43-2.48 (m, 1 H), 2.58-2.65 (m, 2 H), 4.25-4.38 (m, 2 H), 4.51 (d, J = 6.0 Hz, 2 H), 7.20-7.25 (m, 2 H), 7.31-7.43 (m, 3 H), 8.01 (br d, 1 H), 9.76 (s, 1 H). 19F NMR (188 MHz, CDCl3): δ = -78.7 (s, 3 F). IR (KBr): 3375, 2986, 2715, 1759, 1648, 1558, 1453, 1433, 1341, 1240, 1192, 1158, 1038, 970, 737, 665, 461 cm-1. MS (EI): m/z = 357 [M+].